US 9316646
Anti-human ROR1 antibodies
granted A61KA61K2039/505A61K47/6829
Quick answer
US patent 9316646 (Anti-human ROR1 antibodies) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2039/505, A61K47/6829, A61K47/6849, A61P